Sotera Health (SHC) to Release Earnings on Thursday

Sotera Health (NASDAQ:SHC) is expected to be issuing its Q1 2025 quarterly earnings data before the market opens on Thursday, May 1st. Analysts expect Sotera Health to post earnings of $0.12 per share and revenue of $245.56 million for the quarter.

Sotera Health Stock Up 2.3 %

Shares of SHC opened at $10.89 on Thursday. The stock has a fifty day moving average of $11.65 and a 200-day moving average of $13.23. Sotera Health has a 52 week low of $9.53 and a 52 week high of $17.08. The stock has a market capitalization of $3.09 billion, a price-to-earnings ratio of 43.54 and a beta of 1.88. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Piper Sandler reduced their target price on Sotera Health from $15.00 to $13.00 and set a “neutral” rating for the company in a research note on Wednesday. Barclays reduced their target price on Sotera Health from $16.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, April 10th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.20.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.